Milnacipran for the management of fibromyalgia syndrome

Fibromyalgia syndrome (FMS) is a widespread pain condition associated with fatigue, cognitive dysfunction, sleep disturbance, depression, anxiety, and stiffness. Milnacipran is one of three medications currently approved by the Food and Drug Administration in the United States for the management of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ormseth, Michelle J, Eyler, Anne E, Hammonds, Cara L, Boomershine, Chad S
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004654/
https://www.ncbi.nlm.nih.gov/pubmed/21197306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004654/
https://www.ncbi.nlm.nih.gov/pubmed/21197306

Ejemplares similares